Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topiramate as Adjuvant to Cooling for Neonatal HIE
NCT01765218Phase 2Terminated
- Start
- Feb 2013
- Primary completion
- Jan 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of topiramate in hypoxic-ischemic encephalopathy (HIE). Started Feb 2013; status: terminated.
02
Drugs
topiramate
03
Conditions
hypoxic-ischemic encephalopathy (HIE)
Beyond the preview
Go deeper on NCT01765218.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01765218.